Stock Events

Stock Events

Enovis 

$26.06
29
-$0.12-0.46% Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
26.2
Day Low
26.02
52W High
34.28
52W Low
19.14
Volume
64,985
Avg. Volume
-
Mkt Cap
1.5B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 16
$0.19
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.65
0.76
0.87
0.98
Expected EPS
0.774041
Actual EPS
N/A

Financials

-52.69%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.25BRevenue
-1.18BNet Income

Analyst Ratings

39.33Average Price Target
The highest estimate is 51.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENOV. It's not an investment recommendation.
NVIDIA
7
NVDA
Apple
5
AAPL
Amazon
5
AMZN
Intel
5
INTC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Smith & Nephew
SNN
Mkt Cap12.48B
Smith & Nephew competes directly with Enovis in the orthopedics segment, offering similar products for joint replacement and repair.
Stryker
SYK
Mkt Cap130.11B
Stryker is a major competitor in the medical technology field, particularly in orthopedics, surgical equipment, and neurotechnology, directly competing with Enovis' product lines.
Zimmer Biomet
ZBH
Mkt Cap19.2B
Zimmer Biomet Holdings, Inc. is a direct competitor in the orthopedic device market, offering a wide range of products for joint reconstruction, similar to Enovis.
Medtronic
MDT
Mkt Cap116.83B
Medtronic competes with Enovis in multiple areas, including surgical products and patient monitoring systems, making it a broad competitor.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its medical devices segment, competes across several areas with Enovis, including surgical products and orthopedics.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation offers products in various medical fields that overlap with Enovis' offerings, including surgical and orthopedic devices.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories competes with Enovis through its range of medical devices, including vascular and neuromodulation devices, overlapping with Enovis' market.
Globus Medical
GMED
Mkt Cap11.53B
Globus Medical, Inc. competes in the spine orthopedic devices market, offering innovative solutions that rival Enovis' spine-focused products.
Integra Lifesciences
IART
Mkt Cap1.43B
Integra LifeSciences Holdings Corporation offers products in orthopedics and tissue technologies, competing with Enovis in the surgical and orthopedic device market.

About

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Show more...
CEO
Damien McDonald
Employees
7802
Country
United States
ISIN
US1940145022
WKN
000A3DHHV

Listings

STU
DE
C520.STU
MU
DE
C520.MU
F
DE
C520.F
XNYS
US
ENOV

0 Comments

Share your thoughts

FAQ

What is Enovis stock price today?▼
The current price of ENOV is $26.06 USD — it has decreased by -0.46% in the past 24 hours. Watch Enovis stock price performance more closely on the chart.
What is Enovis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Enovis stocks are traded under the ticker ENOV.
Is Enovis stock price growing?▼
ENOV stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Enovis has showed a -17.11% decrease.
What is Enovis market cap?▼
Today Enovis has the market capitalization of 1.5B
When is the next Enovis earnings date?▼
Enovis is going to release the next earnings report on November 11, 2026.
What were Enovis earnings last quarter?▼
ENOV earnings for the last quarter are 0.9 USD per share, whereas the estimation was 0.85 USD resulting in a +6.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Enovis revenue for the last year?▼
Enovis revenue for the last year amounts to 2.25B USD.
What is Enovis net income for the last year?▼
ENOV net income for the last year is -1.18B USD.
How many employees does Enovis have?▼
As of August 23, 2026, the company has 7,802 employees.
In which sector is Enovis located?▼
Enovis operates in the Health & Wellness sector.
When did Enovis complete a stock split?▼
The last stock split for Enovis was on April 05, 2022 with a ratio of 1:3.
Where is Enovis headquartered?▼
Enovis is headquartered in LEWISVILLE, United States.